EDGAR Filing Documents for 0001193125-16-632302

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]

SEC Accession No. 0001193125-16-632302

Filing Date

2016-06-27

Accepted

2016-06-27 09:19:55

Documents

Group Members

BIOVISION LIFE SCIENCE FUND NO.1SBI BB MOBILE INVESTMENT LPSSBI BIO LIFE SCIENCE INVESTMENT LPSSBI CAPITAL MANAGEMENT CO., LTD.SBI INCUBATION CO., LTD.SBI INVESTMENT CO., LTD.SBI PHOENIX NO. 1 INVESTMENT LPS

Document Format Files

Seq	Description	Document	Type	Size
1	SCHEDULE 13D AMENDMENT NO. 12	d200522dsc13da.htm	SC 13D/A	135640
	Complete submission text file	0001193125-16-632302.txt		137659

Mailing Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101

Business Address 1301 SECOND AVE. SUITE 4200 SEATTLE WA 98101 206-805-8300

ACUCELA INC. (Subject) CIK: 0001400482 (see all company filings)

IRS No.: 020592619 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88011 | Film No.: 161732280
SIC: 2834 Pharmaceutical Preparations

Mailing Address IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI MINATO-KU TOKYO M0 106-6019

Business Address IZUMI GARDEN TOWER 19F, 1-6-1 ROPPONGI MINATO-KU TOKYO M0 106-6019 81-3-6229-0122

SBI Holdings, Inc. (Filed by) CIK: 0001446698 (see all company filings)

IRS No.: 000000000 | State of Incorp.: M0 | Fiscal Year End: 0331
Type: SC 13D/A